JPT Peptide Technologies

As part of the deal, the companies will develop peptide-based applications on JPT's high-throughput proteomics screening platform. 

NEW YORK (GenomeWeb News) – JPT Peptide Technologies and The Institute for Medical Immunology at the Charite in Berlin announced on Wednesday an agreement to develop serological peptide biomarkers for the differential diagnosis of chronic fatigue syndrome.

Austrian tools provider Tecan and Berlin-based JPT Peptide Technologies this week announced that they will promote each other's products.

NEW YORK (GenomeWeb News) – Tecan and JPT Peptide Technologies today announced a deal to co-promote JPT's catalog peptide arrays and profiling capabilities.

Arrayjet recently installed a customized version of its Ultra Marathon microarrayer instrument at JPT Technologies.

The Dutch array vendor is working closely with partners in the pharmaceutical industry and academia to optimize internally developed kinase-screening assays for use in drug discovery and as companion diagnostics.

Kinexus President Steven Pelech told BioArray News recently that the new kinase-inhibitor screening service will complement the firm's menu of Kinex antibody and reverse lysate microarrays.

The $6.8 million deal will provide TheraCode with peptide-based services as well as high-content peptide arrays, peptide tools, and peptide libraries.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.